Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026
SiNtx Tech Rg (NASDAQ Cons)
Závěr k 13.2.2026 Změna (%) Změna (USD) Objem obchodů (USD)
3,04 11,58 0,32 69 965
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiSINTX Technologies Inc
TickerSINT
Kmenové akcie:Ordinary Shares
RICSINT.O
ISIN-
Prioritní akcieConv. Pref. Shrs Class B
Prioritní akcieConv. Pref. Shrs Class C
Prioritní akcieConv. Pref. Shrs Series D
Prioritní akcieConv. Pref. Shrs Series E
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 01.03.2025 20
Akcie v oběhu k 07.11.2025 3 851 956
MěnaUSD
Kontaktní informace
Ulice1885 West 2100 Street
MěstoSALT LAKE CITY
PSČ84119
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 018 393 516
Fax18018393605

Business Summary: SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, SINTX Technologies Inc revenues decreased 69% to $728K. Net loss applicable to common stockholders increased 59% to $14.9M. Revenues reflect Grant and contract revenue decrease of 86% to $187K, Product revenue decrease of 49% to $541K. Higher net loss reflects Change in fair value of derivative liab. decrease from $3.5M (income) to $166K (expense), General and administrative increase of 53% to $4.6M (expense).
Odvětvová klasifikace
TRBC2009Managed Health Care
TRBC2012Medical Devices & Implants
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICS2007Surgical Appliance & Supplies Mfg
NAICS1997Surgical Appliance and Supplies Manufacturing
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICSurgical Appliances And Supplies



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerEric Olson6107.03.2025
Chief Financial OfficerKevin Trask4004.09.202504.09.2025
Chief Technology OfficerRyan Bock-01.10.202401.10.2024
Chief Investment Officer, DirectorGregg Honigblum6203.04.202515.11.2024